JSK THERAPEUTICS INC.

SANDY, UT · CIK 0001724999 · Biotech · Private

JS-K, a nitric oxide-releasing small molecule therapeutic that selectively targets malignant cells by exploiting glutathione S-transferase overexpression in cancer cells

Grants
$4.0M
3 awards
Sector median: 1
Raised
$963K
1 Form D · Dec 2017
106 months since last filing
Contracts
—
No federal contracts on record
Patents
3
0 granted · 3 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase II · Clinical Development of JS-K for the Treatment of Cancer$999,183
Federal grantDepartment of Health and Human Services · Phase II · Clinical Development of JS-K for the Treatment of Cancer$1,998,606
Private capital raisedForm D · SEC$962,839
Federal grantDepartment of Health and Human Services · Phase II · Clinical Development of JS-K for the Treatment of Cancer$999,423
Federal grant · SBIR/STTRForm D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2764SAFI BIOTHERAPEUTICS INC——
2765NANOVALENT PHARMACEUTICALS INC——
2766Florey Biosciences, Inc.—$1.4M
2767JSK THERAPEUTICS INC.—$963K
2768Wave Bye Inc.—$852K
2769DIAVACS, INC.—$850K
2770OCEANYX PHARMACEUTICALS, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 5 related persons
  • Dr. Joseph NowoslawskiDirector · Executive Officer
  • Jason OckeyDirector
  • Dinesh PatelDirector
  • Randall PetersonDirector
  • Paul ShamiDirector · Executive Officer

Patents

USPTO · 0 granted of 3
  • Composition And Method For Topical Js-k As Therapy For Actinic Keratosisapplication
  • Composition And Method For Topical Js-k As Therapy For Actinic Keratosisapplication
  • Topical Js-k As Therapy For Actinic Keratosisapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.